TSO3 – Financial Treason & Crime

SPRUCE POINT CAPITAL ISSUES “STRONG SELL” RESEARCH OPINION ON TSO3

ValueWalk, 23 August 2017

TSO3 Inc. (“TSO3” or “the Company”) makes low-temperature sterilization systems to eliminate microbial contaminants that cause infection. Founded in 1998, TSO3 is a regular stock promotion that has repeatedly disappointed investors by failing to broadly commercialize its product and show a profit. Déjà vu, now on its 3rd attempted generation STERIZONE VP4 and its 3rd sales/distribution partner Getinge (previous partner 3M sued it), TSO3 is again baiting investors, who’ve bid its share price up 6x since 2014. Our fundamental and forensic analysis suggests investors should brace for disappointment and >80% downside.

The Canadian markets are littered with recent examples of healthcare stocks in need of urgent medical attention, wounded from over-promotion, questionable practices, and poor performance. Short sellers made early warning calls on many names down >80%: Valeant, Concordia, Nobilis, CRH Medical.
Continue reading “Article: SPRUCE POINT CAPITAL ISSUES “STRONG SELL” RESEARCH OPINION ON TSO3”

Spruce Point Capital Releases a Strong Sell Research Opinion on TSO3, Inc. (CN:TOS, OTC:TSTIF)

Spruce Point Capital Management, 23 August 2017

In late January 2021, GameStop experienced a once-in-a-decade squeeze that has captivated the world’s attention. It was a premeditated and programmatic exercise, orchestrated by coordinated stock and option buying across the retail and professional community, resulting in large institutional entities losing billions of dollars. Investment houses with significant short positions did not expect a stock with GameStop’s fundamental profile to increase +2,500% in price over less than three weeks; therefore, they did not have the controls in place to handle the incredible levels of stock and call option purchases. The frenzy drew comments from the White House, provoked a social media crackdown, caused brokerage units to restrict trading, and has led to a Congressional hearing on GameStop on Thursday, February 18th.
Continue reading “Article: Spruce Point Capital Releases a Strong Sell Research Opinion on TSO3, Inc. (CN:TOS, OTC:TSTIF)”